Loading...
IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy
AIMS: Basal–bolus therapy is associated with greater treatment burden and lower adherence compared with more simplified regimens. This post hoc analysis studied the difference between insulin degludec/liraglutide (IDegLira) and basal–bolus therapy on number of injections, dose adjustments and patien...
Na minha lista:
| Udgivet i: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899651/ https://ncbi.nlm.nih.gov/pubmed/31385425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13851 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|